Study finds potential HIV cure using existing cancer drug

An existing blood cancer drug has shown promise in killing 'silent' HIV cells and delaying reinfections – a significant pre-clinical discovery that could lead to a future cure for the disease.

Related Keywords

Melbourne ,Victoria ,Australia ,Denmark ,Australians ,Australian ,Sharon Lewin ,Marc Pellegrini ,Megan Craig ,Philip Arandjelovic ,Thomas Rasmussen ,Doherty Institute ,University Of Melbourne ,University Of Melbourne Dr Youry Kim ,Australian Centre ,National Health ,Roche Group ,Peter Doherty Institute For Infection ,Defence Division ,Hepatitis Virology Research ,Immunity Doherty Institute ,Genentech ,Research Council ,Denmark Aarhus University ,Sylvia Charles Viertel Senior Medical Research Fellowship ,Peter Doherty Institute ,Professor David Vaux ,Professor Sharon Lewin ,Professor Marc Pellegrini ,Executive Director ,Centenary Institute ,Aarhus University ,Prof Pellegrini ,Immune Defence ,Laureate Professor Sharon Lewin ,Medical Research Council ,Victorian Government ,Royal Melbourne Hospital ,Cell Reports ,Cancer ,Shiv ,Antiretroviral ,Flood ,Blood Cancer ,Cancer Treatment ,D4 ,Fell ,Clinical Trial ,Na ,Hiv 1 ,Immunity ,Medical Research ,Medicine ,Research ,Virus ,